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Background: We examined possible protective effect of Satureja khozestanica essential oil (SKE) on in vivo and
in vitro lipid peroxidation in alloxan-induced Type 1 diabetic rats.
Methods: Thirty Sprage-dawley male rats were divided into three groups randomly; group one as control, group
two diabetic untreatment, and group three treatments with SKE by 500 ppm in drinking water, respectively.
Diabetes was induced in the second and third groups by alloxan injection subcutaneously. After 8 weeks, animals
were anaesthetized, livers and kidneys were then removed immediately and used fresh or kept frozen until their
lipid peroxidation analysis. Lipid peroxidation was determined by measurement of thiobarbituric acid reactive
substances (TBARS). Blood samples were also collected before killing to measure the levels of fasting blood suger
(FBS) and lipid peroxidation.
Results: SKE significantly inhibited the levels of FBS, TBARS serum and kidney content in treated group compared
with the diabetic untreated group. Also the levels of malonedialdehyde liver content unaltered in treated group.
SKE significantly inhibited LDL oxidation in vitro.
Conclusions: The findings showed that SKE exerts beneficial effects on the lipid peroxidation in alloxan-induced
Type 1 diabetic rats.
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Free radicals are generated continuously in the body due
to both normal metabolism and disease [1]. Oxidative stress
is the imbalance between oxidant and antioxidant systems
in favor of the former. Antioxidant systems include antioxi-
dant enzymes such as superoxide dismutase (SOD), catalase
(CAT) and glutathione peroxidase (GPX), in addition
to low molecular agents and dietary antioxidants. Clin-
ical and experimental studies have shown that disturb-
ing of oxidant ? antioxidant balance system is involved
in the pathogenesis of chronic diseases such as cancer
[2], coronary heart disease, diabetes and many diabetic* Correspondence: hassan_a46@yahoo.com
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reproduction in any medium, provided the orcomplications [2]. Hyperglycemia is confounded for
the complications of diabetes because hyperglycemia
directly causes glycation of proteins, lipids and nucleic
acid, then injures cells and induces lipid dperoxidation
[3]. Also antioxidant and antioxidative enzyme activities
reduce due to glycation or increase of lipid peroxidation
products [4]. A number of natural antioxidant such as
vitamin E and phenolic compunds are known to have
hypoglycaemic, hypolipidemic or both activities [5].
Chemical drugs have many side effects; therefore, screen-
ing for new antidiabetic sources from natural antioxidants
is still attractive because they are safe and good alternrtive
for treatment of diabetes mellitus. A growing body of
research indicates that nutritional deficiencies such as
antioxidants contribute to the development of diabetes.
Recently, much attention has been focused on the cen-
tral and key role of oxidative stress in the pathogenesistral. This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and
iginal work is properly credited.
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have shown that antioxidant treatment reduces diabetic
complications [7]. Because of increasing demand of pa-
tients for the use of natural products and other herbal
drugs with anti-diabetic activity, the general trend now
is to use the natural products for medicinal application
in their natural available form [8]. Polyphenols, well-
known antioxidants, have also been showed to function
as antidiabetic by reducing blood glucose levels [9]. Re-
searchers are recently interested in investigation and re-
search into extraction of natural antioxidants from
medical herbs to replace synthetic antioxidants [10].
Therefore, the research into the determination of the
natural antioxidant source is very important to promote
public health [10].
Satureja-khuzestanica, an endemic plant of Iran, de-
creases glucose and malondealdehyde in serum diabetic
patients [10,11]. The components of this extract were
analyzed with gas chromatography/mass spectrometry
(GC/MS) in Research Center of Lorestan University as
reported in our previous paper [11]. The main compo-
nent of this extract is carvacrol as a good antioxidant
[11].
Since the protective effects of SKE on lipid peroxida-
tion status in alloxan-induced type 1 diabetic rats have
not previously been reported; the objectives of the
present study were to investigate amelioration of altered
in vitro and in vivo lipid peroxidation status by Satureja
khozestanica essential oil in alloxan-induced type 1 dia-
betic rats.Table 1 The components of satureja khozestanica essential o
No Compound name Area (%)
1 3-Methyl butanol 0.14
2 Eugenol 1.33
3 1,8-Cineole 0.24
4 α -Pinene 0.99
5 Geranyl acetone 0.5





11 Caryophyllene oxide 1.53
12 4-Terpineol 4.1
13 iso-Butyl-2-methyl butyrate 0.19
14 Heptadecane 0.19
15 Thymyl methyl ether 1.21
16 α-Terpinene 0.73
17 Musk ambrette 0.08
18 Carvacrol 63.17Materials and methods
Isolation of the essential oil from Satureja khozestanica
Satureja khozestanica essential oil was prepared from
cultivated satureja khozestanica in Khoram Abad
(Lorestan province, western Iran). The aerial parts of
the plants were collected during flowering stage and
were air-dried at ambient temperature in the shade.
The aerial parts were hydro-distilled using a Clevenger ap-
paratus for 4 hours, giving yellow oil in 0.9% yield. The oil
was dried over anhydrous sodium sulfate and stored at 4?C.
The plant was previously identified by the Department of
Botany of the Research Institute of Forests and Rangelands
(TARI) in Tehran, Iran. A voucher specimen (No. 58416)
has been deposited at the TARI Herbarium [10]. The
components of Satureja khozestanica essential oil were
analyzed with gas chromatography/mass spectrometry
(GC/MS) in Research Center of Lorestan University
(Table 1).
Animals
Thirty male mature Sprague? Dawley rats (180 ? 200 g)
were obtained from Pasteur Institute of Tehran and
were allowed to adapt themselves with the new location
for one week. This study was approved by the Animal
Ethics Committee of the Medical University of Lorestan
with accordance to the national health and medical re-
search council guidelines. The rats were divided to tree
groups (10 per each). The studied groups were as fol-
lows: group 1 as control, group 2 as diabetic without
treatment and 3rd group as diabetic treatment with SKE.il that analyzed by GC/MS
No Compound name Area (%)
19 β-Phellandrene 0.34
20 α -Thujene 1.26




























Figure 1 The effect of SKE on serum FBS in alloxan induced
diabetic rats. *P < .05 as compared with control group. #P < .05 as
compared with diabetic without treatment group.
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Diabetes was induced after overnight fasting in the second
and third groups by injection of alloxan monohydrate
(120 mg/kg) subcutaneously [10]. Beta cell degradation by
alloxan leads to release of more insulin. Because of acute
hypoglycemia, the rats received 10% sucrose solution for
48 hr instead of drinking water. Five days after induction
of diabetes, blood samples were gathered from the end
part of tails. Blood glucose was measured by glucometer
and the rats with blood glucose level of ≥300 mg/dl
(16.7 mmol/l) were considered as diabetic [10,12]. During
the first five days after diabetes induction, 1? 3 rats per
group died because of alloxan toxicity. The rats were kept
at 12/12 dark ? light period in 21 ? 3?C temperature. All
animals were allowed free access to food and water ad
libitum during the experiment. The third group was
treated with SKE by 500 ppm in drinking water [10].
The treatment was begun at the first day of diabetes in-
duction. After 8 weeks treatment, animals were anesthe-
tized (Nesdonal 50 mg/kg, i.p.), blood samples were
obtained from hearts and allowed to clot for 20 minutes
in laboratory temperature and then centrifuged at
3000 rpm for 10 minutes for serum separation [10].
Also, then liver and kidneys were removed immediately
and used fresh or kept frozen until the analysis.
Levels of FBS
FBS was measured by biochemical analyzer using commer-
cial kits (Olympus AU-600, Tokyo, Japan).
Levels of TBARS
The serum levels of TBARS as a product of lipid peroxida-
tion which reacts with thiobarbituric acid (TBA) analyzed.
Also, then liver and kidney TBARS content were analyzed
[13]. The absorbance was measured spectrophotometric-
ally at 532 nm and the concentrations were expressed as
nmol TBARS /mg-pr.
In vitro oxidation of LDL
Blood samples were taken from healthy human and then
serum was prepared. The LDL fraction was isolated from
fresh serum by single vertical discontinuous density gradi-
ent ultracentrifugation [14]. Lipid peroxidation end prod-
ucts were determined as TBARS according to modified
method of Buege and Aust [13]. After isolation of total
LDL, the protein content of LDL was measured according
to method of Bradford [15]. LDL was adjusted to 150 μg/ml
of LDL protein with 10 mM PBS, pH7.4 and then aliquots
of SKE were added to the solution. After initiating the oxi-
dation process with CuSO4, the sample mixtures were in-
cubated at 37?C for 5 h in a water bath and the reaction
was terminated by adding EDTA (2 mM). TBARS forma-
tion was measured in a spectrophotometer at 532 nm.The results were recorded as TBARS equivalent content
(nmol/mg LDL-protein) (1.56 * 105 M? 1. cm -1) [13].
Statistical analysis
All values are expressed as mean ? SD. The data were
compared between groups by Mann ? Whitney U test.
Statistical analyses were performed using the SPSS 13
for windows software. A P value of < 0.05 was considered
statistically significant.
Results
Effect of SKE on FBS of diabetic rats
The levels of FBS are shown in Figure 1. Diabetes signifi-
cantly increased serum FBS in comparison with the control
group. Treatment of diabetic animals with SKE signifi-
cantly inhibited increase of serum FBS in comparison
with the untreated diabetic animals
Effect of SKE on serum TBARS of diabetic rats
The levels of TBARS in serum are shown in Figure 2. The
level of TBARS in the untreated diabetic rats was signifi-
cantly (1.3-fold) higher than that of control animals. The
level of TBARS in the serum of diabetic rats treated with
SKE was very low, similar to the level found in the control
animals. The treatment of diabetic animal with SKE could
significantly (23%) inhibit the increase of TBARS in com-
parison with the untreated diabetic animals.
Effect of SKE on kidney TBARS content of diabetic rats
The level of renal TBARS in the untreated diabetic rats
was significantly (1.4-fold) higher than that of control ani-
mals. The treatment of diabetic animal with SKE could
significantly (33%) inhibit the increase of TBARS in com-
parison with the untreated diabetic animals (Figure 3).
Effect of SKE on liver TBARS content of diabetic rats
The level of liver TBARS in the untreated diabetic rats
















Figure 2 The effect of SKE on serum TBARS in alloxan induced
diabetic rats. *P < .05 as compared with control group. #P < .05 as
















Figure 4 The effect of SKE on Liver TBARS content in alloxan
induced diabetic rats. *P < .05 as compared with control group.
#P < .05 as compared with diabetic without treatment group.
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(2%) inhibit the increase of TBARS in comparison with
the untreated diabetic animals, but it was not significant
(Figure 4).
In vitro oxidation of LDL
The levels of TBARS after 5 h of incubation in all ex-
periment groups are shown in Figure 5. Vitamin E sig-
nificantly inhibited TBARS formation (P < 0.01). SKE
exhibited a dose-dependent inhibition of TBARS forma-
tion. SKE (50, 100, 200 μg/m1) significantly was inhibited
by the TBARS production in LDL (P < 0.01 and P < 0.001)
respectively.
Discussion
This study showed that SKE has protective effects on
glomerular hypertrophy, glomerulosclerosis and loss of
glomerular volume in alloxan-induced-diabetic rats.
There is much evidence that oxidative stress play a key
role in the most pathogenic pathway of diabetic injur-
ies. Free radicals such as superoxide can induce cell
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Figure 3 The effect of SKE on kidney TBARS content in alloxan
induced diabetic rats. *P < .05 as compared with control group.
#P < .05 as compared with diabetic without treatment group.increase carcinogenesis, inflammation, early aging, car-
diovascular diseases and tissue damage in diabetes [12].
Herbal extracts such as Artemisia afra Jacq, Aframomum
melegueta and Aloe vera gel extracts [16] and antioxidants
such as vitamin E, coenzyme Q10 and antioxidant en-
zymes such as SOD, GPX and CAT protect the cells
against oxidative stress mediated cellular injuries by
converting the toxic free radicals to non-toxic products
[17]. Therefore use of antioxidant as complementary ther-
apy is useful for diseases that related to oxidative stress.
Effect of SKE on serum lipid peroxidation
Diabetes significantly increased serum, liver and kidney
lipid peroxidation in comparison with the control group.
Treatment of diabetic animals with SKE significantly
inhibited decrease of serum and kidney lipid peroxida-
tion in comparison with the untreated diabetic animals.
There are reports that natural antioxidant such as vita-
min E, vitamin C, lipoic acid, aminoguanidine, turine,
N-acetylcysteine, allopurinollycopene and natural phenolic
compounds have protective effects on lipid peroxidation
in diabetics disease [18,19]. Many studies indicated that
various herbal extracts have protective effects on lipid per-
oxidation in different disease. For example aloe vera gel,
Helicteres isora bark extracts and grape seed (Vitis vinifera)
extract extract ameliorate the oxidative stress in animal
model [17].
Moreover; beneficial effects of SKE as antioxidant, anti-
diabetic, anti-inflammatory and anti-hyperlipidemia, tox-
icity and terato-genicity tests were also performed and
confirmed plant? s safety [10]; moreover, this extract can be
produced in large amount and low cost. Because of safety
of SKE, a polyphenolic compound with antioxidant and
anti-inflammatory properties, consumption of SKE is in-
troduced to diabetic patients. Results of our study are in
accordance with others researcher's study that showed
SKE could reduce serum lipid peroxidation level. There-
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Figure 5 The effects of SKE on the formation of TBARS. The effects of SKE on LDL oxidation in l0 mM PBS, pH 7.4 at 37?C for 5 h. (C)
n-LDL, (Cu) n-LDL + copper, (SKE1) n-LDL + SKE (50 μg/m1), (SKE2) n-LDL + SKE (100 μg/m1), (SKE3) n- LDL + SKE (200 μg/m1) and
(E1) n-LDL + Vitamin E(100 μM). Each point represents the mean of five experiments.
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complications that related to oxidative stress in diabetes
patients.
In vitro antioxidant activity of SKE
The results clearly showed that various concentration of
SKE have a dose-dependent antioxidant activity by inhibit-
ing the formation of TBARS of LDL in vitro. The results
showed that SKE especially at 200 μg/m1concentration
similar to vitamin E as a positive control is a potent anti-
oxidant and protect LDL in plasma against oxidation. Re-
sults of our study showed that SKE has beneficial effects,
in decreasing lipid peroxidation in vitro and in vivo. Our
results indicated that SKE is found to posses a good anti-
oxidant activity. The difference in the amount of antioxi-
dant of extracts may be attributed to the differences in the
amount and kind of existing antioxidant compounds in
them such as carotenoids, phenol and ascorbic acid [20].
The main constituents found in the SKE were Carvacrol
(63.17%); para-Cymene (5.61%); 4-Terpineol (4.1%);
β-Bisabolene (3.77%); Linalool (3.32%); γ-Terpinene
(2.77); Myrcene (2.43%) (Table 1). The antioxidant activity
has been shown by the SKE may be due to the presence of
carvacrol, para-Cymene, 4-Terpineol, β-Bisabolene and
Linalool [10,20]. Carvacrol is a good antioxidant-scavenger
of peroxyl radicals and anti-inflammatory property
[10,20]. Also researchers reported the role of oxidative
stress as a central factor in onset and progression of
diabetic complications such as vascular defects and ne-
phropathy [5]. Inspite of numerous reports and our re-
sults that showed efficacy of antioxidative supplements
administration in the prevention of diabetic complica-
tions. Since antioxidant therapy as one of the most im-
portant treatment strategies for diabetic patients for
the prevention and slowing of diabetic complications
progression such as hyperlipemia, hepatic damage. In
diabetic nephropathy, structural injury develops over
years before clinical and laboratory abnormalities suchas albuminuria, hypertension, or declining glomerular
filtration rate (GFR) appear. Thus, waiting for clinical
or laboratory manifestation of renal disease before initiat-
ing treatment may hinder efforts that prevent progression
to end stage of renal disease. Although the detailed mo-
lecular protective mechanisms of SKE can not be fully
explained by our results, our results are satisfactory. SKE
as a source of potent antioxidants. With multi beneficial
properties can be introduced to diabetic patients without
diabetic nephropathy for inhibition and progression of
diabetic nephropathy.
Conclusion
This study showed that SKE has protective effects on lipid
peroxidation, glomerular hypertrophy, glomerulosclerosis
and leukocyte infiltration in alloxan-induced-diabetic
rats. Hence, attenuation of lipid peroxidation can decrease
diabetic complication such as nephropathy in diabetic
patients.
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